ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 250 filers reported holding ACADIA PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 0.73 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $986,000 | -1.2% | 23,333 | 0.0% | 0.02% | +23.5% |
| Q4 2019 | $998,000 | +39.2% | 23,333 | +17.1% | 0.02% | +21.4% |
| Q3 2019 | $717,000 | +34.5% | 19,932 | 0.0% | 0.01% | +27.3% |
| Q2 2019 | $533,000 | -0.4% | 19,932 | 0.0% | 0.01% | -8.3% |
| Q1 2019 | $535,000 | +66.1% | 19,932 | 0.0% | 0.01% | +50.0% |
| Q4 2018 | $322,000 | -3.3% | 19,932 | +24.3% | 0.01% | +60.0% |
| Q3 2018 | $333,000 | +35.9% | 16,032 | 0.0% | 0.01% | 0.0% |
| Q2 2018 | $245,000 | -29.0% | 16,032 | +4.6% | 0.01% | -37.5% |
| Q1 2018 | $345,000 | -48.5% | 15,332 | -31.1% | 0.01% | 0.0% |
| Q4 2017 | $670,000 | – | 22,264 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Finepoint Capital LP | 556,553 | $11,598,565 | 5.78% |
| Baker Brothers Advisors | 42,864,612 | $893,298,514 | 5.15% |
| RTW INVESTMENTS, LP | 11,576,537 | $241,255,031 | 5.09% |
| Palo Alto Investors LP | 2,405,793 | $50,136,726 | 4.74% |
| Birchview Capital, LP | 240,400 | $5,009,936 | 4.26% |
| EcoR1 Capital, LLC | 5,991,479 | $124,862,422 | 4.21% |
| EMERALD ADVISERS, LLC | 1,681,052 | $35,033,124 | 1.70% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,303,988 | $27,175,110 | 1.64% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 179,702 | $3,739,599 | 1.26% |
| SECTOR GAMMA AS | 179,785 | $3,746,719 | 0.96% |